California stem cell chairman Robert Klein has discussed his trip to South Korea, litigation against CIRM and the financial benefits of stem research in an interview with Capitol Weekly in Sacramento.
He estimated the lawsuits could take as much as 15 months to go through the appeals process. He said the journey to Asia was a "general trip to look at the full range of research in Korea and to have talks with the Korean government on their future commitments, which they have expanded substantially." He did not mention the name of Woo Suk Hwang.
He also said the $1.1 billion royalty figures supplied by a study commissioned by the Prop. 71 campaign have been taken out of context.
The hour-long interview was conducted by Capitol Weekly reporter Malcolm Maclachlan.
No comments:
Post a Comment